Back to search

Article

In vivo CRISPR screens reveal SCAF1 and USP15 as novel drivers of pancreatic cancer

2022-12-22

Abstract excerpt

<title>Abstract</title> <p>Functionally characterizing the genetic alterations that drive pancreatic cancer is a prerequisite for precision medicine. Here, we performed somatic CRISPR/Cas9 mutagenesis screens to assess the transforming potential of 125 recurrently mutated pancreatic cancer genes, which revealed USP15 and SCAF1 as novel pancreatic tumor suppressors. Mechanistically, we found that USP15 functions i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b46447ca-750b-5daf-bf5d-7db36241dcd8
DOI
10.21203/rs.3.rs-2352174/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In vivo CRISPR screens reveal SCAF1 and USP15 as novel drivers of pancreatic cancerDOI 10.21203/rs.3.rs-2352174/v1
Select a neighboring publication to make it the new centre.